Ridgetech Inc.

RDGT Healthcare Pharmaceutical Retailers

Ridgetech Inc.’s revenue for fiscal 2026 (year ended March 2026) was $132.2 million, up 10.2% from fiscal 2025. Insiders bought in the last twelve months.

0.84 0.01 +1.20%
Market cap
$3.0M
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
4/9
Altman Z
1.16
Beneish M
−2.32
Dividend safety
n/a
Sep '25 Mar '23 Sep '22 Mar '22 Older periods
P/E ratio
— 0.00 0.00 0.00

+8 more quarters

P/S ratio
— 453.96 97.72 14.17
P/FCF ratio
— 0.00 3,540.35 0.00
P/Operating CF
— (32,751.27) 25,205.56 (567.65)
P/B ratio
— 7,892.92 1,145.21 138.66
EV/Sales
— 454.00 97.77 14.23
EV/EBITDA
— 0.00 0.00 0.00
EV/FCF
— (15,460.54) 3,541.96 (595.85)
Current Ratio
1.82 0.97 1.01 1.01
Net Debt/EBITDA
0.00 0.00 0.00 0.00
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
— (0.09%) (0.18%) (46.75%)
Free Cash Flow Yield
— (0.01%) 0.03% (0.17%)
Free Cash Flow per Share
0.00 (0.41) 0.23 (20.29)
Book value per Share
0.00 0.00 0.00 0.00
Free Cash Flow
5.35 (4.34) 1.06 (5.88)
EV/EBIT
— 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates